Loading…
An in-silico based clinical insight on the effect of noticeable CD4 conserved residues of SARS-CoV-2 on the CD4-MHC-I interactions
The study is aimed to unveil the conserved residues of CD4 in the context of its purposeful interaction with MHC-II at the receptor-binding domain (RBD) of SARS-CoV-2 compared with the envelope (Env) glycoprotein (gp) 120 of HIV-1. The paired CD4 conserved residues, including the matched CD4 interac...
Saved in:
Published in: | bioRxiv 2020-06 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Request full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | |
container_start_page | |
container_title | bioRxiv |
container_volume | |
creator | Chellasamy, Selvaakumar Senthil, Arun Kumar Dasgupta, Debjani Wei, Haiyan |
description | The study is aimed to unveil the conserved residues of CD4 in the context of its purposeful interaction with MHC-II at the receptor-binding domain (RBD) of SARS-CoV-2 compared with the envelope (Env) glycoprotein (gp) 120 of HIV-1. The paired CD4 conserved residues, including the matched CD4 interacting MHC-II epitopes of the structural viral protein domains, were chosen for the protein modelling using the SWISS-MODEL online server. Energy minimization and structural validation of the modelled viral protein domains, including the CD4 and MHC-II protein were achieved by CHIMERA and PROCHECK-Ramachandran Plot respectively. Protein-protein docking was performed by the HADDOCK online tool. The binding affinity score was measured using the PRODIGY online server. As per our docking report, the Env gp120 of HIV-1 with three identical and three conserved residues of CD4 exhibited the highest binding affinity (-13.9 kcal/mol) with MHC-II than the second-highest RBD-S1-SARS-CoV-2 (-12.5 kcal/mol) with three identical and a single conserved residue of CD4. With a noticeable single salt bridge formation identified at the interacting residues Lys305 (of Env gp120-HIV-1) and Glu139 (of MHC-II); the Env gp120 interaction with MHC-II occupied the crucial His144 and Glu194 (salt-bridge) interacting residues of CD4 with the measured buried surface area 2554.8±40.8 Å2. Similarly, the RBD-S1-SARS-CoV-2-MHC-II complex showed two salt bridge formations at the residue sites: 1) Arg567 (of SARS-CoV-2)-Glu194 (of MHC-II) 2) 2) Asp568(of SARS-CoV-2)-Arg165 (of MHC-II) with the increased buried surface area of 1910.9±97.1 Å2 over the SARS-CoV score 1708.2±50.8 Å2 that camouflaged all crucial CD4 interacting residues of MHC-II. In conclusion, the noticeable conserved residues of CD4 at the RBD-S1 sites of SARS-CoV-2 could interrupt the aspired CD4-MHC-II interactions of adaptive immune activation. Competing Interest Statement The authors have declared no competing interest. |
doi_str_mv | 10.1101/2020.06.19.161802 |
format | article |
fullrecord | <record><control><sourceid>proquest_COVID</sourceid><recordid>TN_cdi_proquest_journals_2414912215</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2414912215</sourcerecordid><originalsourceid>FETCH-proquest_journals_24149122153</originalsourceid><addsrcrecordid>eNqNjLFuAjEQRN1QIMgH0K1E7YvXuZxCeToSkSINRGmR8e2FRZYNti8fkC-PkUhPNRrNmyfEAlWFqPBRK60q1VS4qrDBF6Wn4rf1wF4mdmwDHEyiHqxjz9a4MiT-PmYIHvKRgIaBbGkD-JDZkjk4gm5dgw0-Ufwp10iJ-5HSFdq1253swpfU_4LCyo9NJ9-LOVM0NnN5zsVkMC7Rwy1nYvn2-tlt5DmGS3Hl_SmM0Zdpr2usV6g1Pj_dR_0B5YNODA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2414912215</pqid></control><display><type>article</type><title>An in-silico based clinical insight on the effect of noticeable CD4 conserved residues of SARS-CoV-2 on the CD4-MHC-I interactions</title><source>Coronavirus Research Database</source><creator>Chellasamy, Selvaakumar ; Senthil, Arun Kumar ; Dasgupta, Debjani ; Wei, Haiyan</creator><creatorcontrib>Chellasamy, Selvaakumar ; Senthil, Arun Kumar ; Dasgupta, Debjani ; Wei, Haiyan</creatorcontrib><description>The study is aimed to unveil the conserved residues of CD4 in the context of its purposeful interaction with MHC-II at the receptor-binding domain (RBD) of SARS-CoV-2 compared with the envelope (Env) glycoprotein (gp) 120 of HIV-1. The paired CD4 conserved residues, including the matched CD4 interacting MHC-II epitopes of the structural viral protein domains, were chosen for the protein modelling using the SWISS-MODEL online server. Energy minimization and structural validation of the modelled viral protein domains, including the CD4 and MHC-II protein were achieved by CHIMERA and PROCHECK-Ramachandran Plot respectively. Protein-protein docking was performed by the HADDOCK online tool. The binding affinity score was measured using the PRODIGY online server. As per our docking report, the Env gp120 of HIV-1 with three identical and three conserved residues of CD4 exhibited the highest binding affinity (-13.9 kcal/mol) with MHC-II than the second-highest RBD-S1-SARS-CoV-2 (-12.5 kcal/mol) with three identical and a single conserved residue of CD4. With a noticeable single salt bridge formation identified at the interacting residues Lys305 (of Env gp120-HIV-1) and Glu139 (of MHC-II); the Env gp120 interaction with MHC-II occupied the crucial His144 and Glu194 (salt-bridge) interacting residues of CD4 with the measured buried surface area 2554.8±40.8 Å2. Similarly, the RBD-S1-SARS-CoV-2-MHC-II complex showed two salt bridge formations at the residue sites: 1) Arg567 (of SARS-CoV-2)-Glu194 (of MHC-II) 2) 2) Asp568(of SARS-CoV-2)-Arg165 (of MHC-II) with the increased buried surface area of 1910.9±97.1 Å2 over the SARS-CoV score 1708.2±50.8 Å2 that camouflaged all crucial CD4 interacting residues of MHC-II. In conclusion, the noticeable conserved residues of CD4 at the RBD-S1 sites of SARS-CoV-2 could interrupt the aspired CD4-MHC-II interactions of adaptive immune activation. Competing Interest Statement The authors have declared no competing interest.</description><identifier>DOI: 10.1101/2020.06.19.161802</identifier><language>eng</language><publisher>Cold Spring Harbor: Cold Spring Harbor Laboratory Press</publisher><subject>Affinity ; CD4 antigen ; Epitopes ; Glycoprotein gp120 ; HIV ; Human immunodeficiency virus ; Immune response ; Internet ; Major histocompatibility complex ; Proteins ; Severe acute respiratory syndrome coronavirus 2 ; Surface area</subject><ispartof>bioRxiv, 2020-06</ispartof><rights>2020. This article is published under http://creativecommons.org/licenses/by-nd/4.0/ (“the License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2414912215?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>776,780,27902,38493,43871</link.rule.ids><linktorsrc>$$Uhttps://www.proquest.com/docview/2414912215?pq-origsite=primo$$EView_record_in_ProQuest$$FView_record_in_$$GProQuest$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Chellasamy, Selvaakumar</creatorcontrib><creatorcontrib>Senthil, Arun Kumar</creatorcontrib><creatorcontrib>Dasgupta, Debjani</creatorcontrib><creatorcontrib>Wei, Haiyan</creatorcontrib><title>An in-silico based clinical insight on the effect of noticeable CD4 conserved residues of SARS-CoV-2 on the CD4-MHC-I interactions</title><title>bioRxiv</title><description>The study is aimed to unveil the conserved residues of CD4 in the context of its purposeful interaction with MHC-II at the receptor-binding domain (RBD) of SARS-CoV-2 compared with the envelope (Env) glycoprotein (gp) 120 of HIV-1. The paired CD4 conserved residues, including the matched CD4 interacting MHC-II epitopes of the structural viral protein domains, were chosen for the protein modelling using the SWISS-MODEL online server. Energy minimization and structural validation of the modelled viral protein domains, including the CD4 and MHC-II protein were achieved by CHIMERA and PROCHECK-Ramachandran Plot respectively. Protein-protein docking was performed by the HADDOCK online tool. The binding affinity score was measured using the PRODIGY online server. As per our docking report, the Env gp120 of HIV-1 with three identical and three conserved residues of CD4 exhibited the highest binding affinity (-13.9 kcal/mol) with MHC-II than the second-highest RBD-S1-SARS-CoV-2 (-12.5 kcal/mol) with three identical and a single conserved residue of CD4. With a noticeable single salt bridge formation identified at the interacting residues Lys305 (of Env gp120-HIV-1) and Glu139 (of MHC-II); the Env gp120 interaction with MHC-II occupied the crucial His144 and Glu194 (salt-bridge) interacting residues of CD4 with the measured buried surface area 2554.8±40.8 Å2. Similarly, the RBD-S1-SARS-CoV-2-MHC-II complex showed two salt bridge formations at the residue sites: 1) Arg567 (of SARS-CoV-2)-Glu194 (of MHC-II) 2) 2) Asp568(of SARS-CoV-2)-Arg165 (of MHC-II) with the increased buried surface area of 1910.9±97.1 Å2 over the SARS-CoV score 1708.2±50.8 Å2 that camouflaged all crucial CD4 interacting residues of MHC-II. In conclusion, the noticeable conserved residues of CD4 at the RBD-S1 sites of SARS-CoV-2 could interrupt the aspired CD4-MHC-II interactions of adaptive immune activation. Competing Interest Statement The authors have declared no competing interest.</description><subject>Affinity</subject><subject>CD4 antigen</subject><subject>Epitopes</subject><subject>Glycoprotein gp120</subject><subject>HIV</subject><subject>Human immunodeficiency virus</subject><subject>Immune response</subject><subject>Internet</subject><subject>Major histocompatibility complex</subject><subject>Proteins</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Surface area</subject><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><recordid>eNqNjLFuAjEQRN1QIMgH0K1E7YvXuZxCeToSkSINRGmR8e2FRZYNti8fkC-PkUhPNRrNmyfEAlWFqPBRK60q1VS4qrDBF6Wn4rf1wF4mdmwDHEyiHqxjz9a4MiT-PmYIHvKRgIaBbGkD-JDZkjk4gm5dgw0-Ufwp10iJ-5HSFdq1253swpfU_4LCyo9NJ9-LOVM0NnN5zsVkMC7Rwy1nYvn2-tlt5DmGS3Hl_SmM0Zdpr2usV6g1Pj_dR_0B5YNODA</recordid><startdate>20200619</startdate><enddate>20200619</enddate><creator>Chellasamy, Selvaakumar</creator><creator>Senthil, Arun Kumar</creator><creator>Dasgupta, Debjani</creator><creator>Wei, Haiyan</creator><general>Cold Spring Harbor Laboratory Press</general><scope>8FE</scope><scope>8FH</scope><scope>AAFGM</scope><scope>AAMXL</scope><scope>ABOIG</scope><scope>ABUWG</scope><scope>ADZZV</scope><scope>AFKRA</scope><scope>AFLLJ</scope><scope>AFOLM</scope><scope>AGAJT</scope><scope>AQTIP</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQCXX</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20200619</creationdate><title>An in-silico based clinical insight on the effect of noticeable CD4 conserved residues of SARS-CoV-2 on the CD4-MHC-I interactions</title><author>Chellasamy, Selvaakumar ; Senthil, Arun Kumar ; Dasgupta, Debjani ; Wei, Haiyan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-proquest_journals_24149122153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Affinity</topic><topic>CD4 antigen</topic><topic>Epitopes</topic><topic>Glycoprotein gp120</topic><topic>HIV</topic><topic>Human immunodeficiency virus</topic><topic>Immune response</topic><topic>Internet</topic><topic>Major histocompatibility complex</topic><topic>Proteins</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Surface area</topic><toplevel>online_resources</toplevel><creatorcontrib>Chellasamy, Selvaakumar</creatorcontrib><creatorcontrib>Senthil, Arun Kumar</creatorcontrib><creatorcontrib>Dasgupta, Debjani</creatorcontrib><creatorcontrib>Wei, Haiyan</creatorcontrib><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection (Proquest) (PQ_SDU_P3)</collection><collection>Biological Sciences</collection><collection>Biological Science Database</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Chellasamy, Selvaakumar</au><au>Senthil, Arun Kumar</au><au>Dasgupta, Debjani</au><au>Wei, Haiyan</au><format>book</format><genre>document</genre><ristype>GEN</ristype><atitle>An in-silico based clinical insight on the effect of noticeable CD4 conserved residues of SARS-CoV-2 on the CD4-MHC-I interactions</atitle><jtitle>bioRxiv</jtitle><date>2020-06-19</date><risdate>2020</risdate><abstract>The study is aimed to unveil the conserved residues of CD4 in the context of its purposeful interaction with MHC-II at the receptor-binding domain (RBD) of SARS-CoV-2 compared with the envelope (Env) glycoprotein (gp) 120 of HIV-1. The paired CD4 conserved residues, including the matched CD4 interacting MHC-II epitopes of the structural viral protein domains, were chosen for the protein modelling using the SWISS-MODEL online server. Energy minimization and structural validation of the modelled viral protein domains, including the CD4 and MHC-II protein were achieved by CHIMERA and PROCHECK-Ramachandran Plot respectively. Protein-protein docking was performed by the HADDOCK online tool. The binding affinity score was measured using the PRODIGY online server. As per our docking report, the Env gp120 of HIV-1 with three identical and three conserved residues of CD4 exhibited the highest binding affinity (-13.9 kcal/mol) with MHC-II than the second-highest RBD-S1-SARS-CoV-2 (-12.5 kcal/mol) with three identical and a single conserved residue of CD4. With a noticeable single salt bridge formation identified at the interacting residues Lys305 (of Env gp120-HIV-1) and Glu139 (of MHC-II); the Env gp120 interaction with MHC-II occupied the crucial His144 and Glu194 (salt-bridge) interacting residues of CD4 with the measured buried surface area 2554.8±40.8 Å2. Similarly, the RBD-S1-SARS-CoV-2-MHC-II complex showed two salt bridge formations at the residue sites: 1) Arg567 (of SARS-CoV-2)-Glu194 (of MHC-II) 2) 2) Asp568(of SARS-CoV-2)-Arg165 (of MHC-II) with the increased buried surface area of 1910.9±97.1 Å2 over the SARS-CoV score 1708.2±50.8 Å2 that camouflaged all crucial CD4 interacting residues of MHC-II. In conclusion, the noticeable conserved residues of CD4 at the RBD-S1 sites of SARS-CoV-2 could interrupt the aspired CD4-MHC-II interactions of adaptive immune activation. Competing Interest Statement The authors have declared no competing interest.</abstract><cop>Cold Spring Harbor</cop><pub>Cold Spring Harbor Laboratory Press</pub><doi>10.1101/2020.06.19.161802</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | DOI: 10.1101/2020.06.19.161802 |
ispartof | bioRxiv, 2020-06 |
issn | |
language | eng |
recordid | cdi_proquest_journals_2414912215 |
source | Coronavirus Research Database |
subjects | Affinity CD4 antigen Epitopes Glycoprotein gp120 HIV Human immunodeficiency virus Immune response Internet Major histocompatibility complex Proteins Severe acute respiratory syndrome coronavirus 2 Surface area |
title | An in-silico based clinical insight on the effect of noticeable CD4 conserved residues of SARS-CoV-2 on the CD4-MHC-I interactions |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T15%3A20%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_COVID&rft_val_fmt=info:ofi/fmt:kev:mtx:book&rft.genre=document&rft.atitle=An%20in-silico%20based%20clinical%20insight%20on%20the%20effect%20of%20noticeable%20CD4%20conserved%20residues%20of%20SARS-CoV-2%20on%20the%20CD4-MHC-I%20interactions&rft.jtitle=bioRxiv&rft.au=Chellasamy,%20Selvaakumar&rft.date=2020-06-19&rft_id=info:doi/10.1101/2020.06.19.161802&rft_dat=%3Cproquest_COVID%3E2414912215%3C/proquest_COVID%3E%3Cgrp_id%3Ecdi_FETCH-proquest_journals_24149122153%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2414912215&rft_id=info:pmid/&rfr_iscdi=true |